Showing results (321-330 of 870) with videos related to
Sort By:
Pageof 87
Thrombosis Research|September 15, 1986
Studies on liposome-encapsulated heparinT D Kim, M Sakon, T Kawasaki, et al.Atherosclerosis|October 5, 2001
High-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cellsS Nomura, N N Tandon, T Nakamura, et al.European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|January 1, 1990
Modification of septic processes by beta-glucan administrationT Tsujinaka, M Yokota, J Kambayashi, et al.The Journal of Pharmacology and Experimental Therapeutics|March 1, 2025
Drug-induced long QT syndrome: Concept and nonclinical models for predicting the onset of drug-induced torsade de pointes in patients in compliance with International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) E14/S7B guidanceAtsushi Sugiyama, Ai Goto, Hiroko Izumi-Nakaseko, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 21, 2003
Memory CD8+ T cells provide an early source of IFN-gammaTaku Kambayashi, Erika Assarsson, Aron E Lukacher, et al.The Journal of Pharmacology and Experimental Therapeutics|October 17, 2001
OPC-28326, a selective femoral vasodilator, is an alpha2C-adrenoceptor-selective antagonistB Sun, S Lockyer, J Li, et al.International Journal of Immunopharmacology|June 1, 1996
Vesnarinone is a selective inhibitor of macrophage TNF(alpha) releaseT Kambayashi, N Mazurek, C O Jacob, et al.Molecular Immunology|December 21, 2004
2B4 co-stimulation: NK cells and their control of adaptive immune responsesErika Assarsson, Taku Kambayashi, Catrine M Persson, et al.International Journal of Clinical Pharmacology and Therapeutics|June 23, 2005
Safety, tolerability and pharmacokinetics of oral S-3304, a novel matrix metalloproteinase inhibitor, in single and multiple dose escalation studies in healthy volunteersS van Marle, A van Vliet, F Sollie, et al.Surgery Today|January 1, 1995
Suppression of pseudointimal hyperplasia by a novel prostacyclin analogue: beraprostD I Kim, J Kambayashi, T Shibuya, et al.Pageof 87